Skip to content
MedsAcross

Molecule

Albumin human

Human Serum Albumin
Available on requestBiologic
Presentations
45
Brands
9
Manufacturers
6
Available from stock
0

Albumin human is a human serum albumin indicated for hypovolemia and Hypoalbuminemia, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Albumin human for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Human Serum Albumin, Serum Albumin [Chemical/Ingredient], Osmotic Activity, Increased Intravascular Volume, Increased Oncotic Pressure
US FDA first approval
31 December 1997
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Intravenous
Dosage forms
Injection
Biologic
Yes
Identifiers
UNII ZIF514RVZR

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

1. INDICATIONS AND USAGE KEDBUMIN® is a 25% albumin solution indicated for: Hypovolemia and Hypoalbuminemia. Prevention of central volume depletion after paracentesis due to cirrhotic ascites. Ovarian hyperstimulation syndrome (OHSS). Adult Respiratory Distress Syndrome (ARDS). Burns. Hemodialysis patients undergoing long term dialysis. Patients who cannot tolerate substantial volumes of salt solution. Priming as part of a cardiopulmonary bypass fluids

Source: US FDA prescribing information

How it works

Human albumin is not a glycoprotein. It has the lowest molecular weight (66,241 Daltons) of all plasma proteins. Because of its three dimensional structure, solutions of albumin have a lower viscosity than solutions of other plasma proteins. This is important since work performed by the heart depends in part on the viscosity of blood. Human albumin accounts quantitatively for more than half of the total proteins in the circulation (by weight) and represents approximately 10 % of the protein synthesized in the liver. Approximately 40% of albumin is contained in the circulation. The remainder is located in the extravascular space of tissues, principally muscle, skin, and intestine. KEDBUMIN® 25% has a hyperoncotic effect. A major function of albumin is its role in osmotic regulation. Albumin is responsible for 75% of normal oncotic pressure within the intravascular space [13, 14].

Source: US FDA prescribing information

Dosing overview

2. DOSAGE AND ADMINISTRATION Intravenous Administration Only. Intravenous Administration Only. KEDBUMIN® may be diluted with 5% glucose or 0.9% sodium chloride. Concentration, dosage, and infusion-rate should be adjusted to the patient's individual requirements and indication. Daily dosage should not exceed 2g per kg body weight. Indication: Dose Hypovolemia: Adults: Initial dose 25 g is suggested.

Source: US FDA prescribing information

Contraindications

4. CONTRAINDICATIONS KEDBUMIN® is contraindicated in patients with a history of hypersensitivity to albumin, excipients used in its formulation, or components of the container [11]. KEDBUMIN® is also contraindicated in severely anemic patients and in patients with heart failure. Severe anemia or heart failure in the presence of normal or increased intravascular volume. Hypersensitivity to albumin, the excipients, or components of the container.

Source: US FDA prescribing information

Warnings and precautions

5. WARNINGS AND PRECAUTIONS Risk of transmission of infectious agents. Caution where hypervolemia and its consequences or hemodilution could represent a special risk. Do not dilute with water for injection

Source: US FDA prescribing information

Side effects

6. ADVERSE REACTIONS The most common adverse reactions include fever, chills, rash, nausea, vomiting, tachycardia, and hypotension.

Source: US FDA prescribing information

Interactions

7. DRUG INTERACTION KEDBUMIN® should not be mixed with other medicinal products including blood and blood components, but can be administered concomitantly with other parenterals such as whole blood, plasma, saline, glucose or sodium lactate when medically necessary. KEDBUMIN® should not be mixed with protein hydrolysates or solutions containing alcohol since these combinations may cause protein precipitation.

Source: US FDA prescribing information

Storage

Do not store above 30°C (86° F). Do not freeze. Keep the vial stored in the outer carton in order to protect from light.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

45 presentations of Albumin human, sorted by availability.

MedicineManufacturerRegisterAvailability
Albutein 12.5 g/250 mL injectionIntravenousGrifolsUS FDAAvailable on request
Albutein 25 g/500 mL injectionIntravenousGrifolsUS FDAAvailable on request
Albutein 10 g/50 mL injectionIntravenousGrifolsUS FDAAvailable on request
Albutein 12.5 g/50 mL injectionIntravenousGrifolsUS FDAAvailable on request
Albutein 20 g/100 mL injectionIntravenousGrifolsUS FDAAvailable on request
Albutein 25 g/100 mL injectionIntravenousGrifolsUS FDAAvailable on request
Albuked 10 g/50 mL injectionIntravenousKedrion BiopharmaUS FDAAvailable on request
Albuked 12.5 g/250 mL injectionIntravenousKedrion BiopharmaUS FDAAvailable on request
Albuked 12.5 g/50 mL injectionIntravenousKedrion BiopharmaUS FDAAvailable on request
Albuked 2.5 g/50 mL injectionIntravenousKedrion BiopharmaUS FDAAvailable on request
Albuked 20 g/100 mL injectionIntravenousKedrion BiopharmaUS FDAAvailable on request
Albuked 25 g/100 mL injectionIntravenousKedrion BiopharmaUS FDAAvailable on request
Albuked 5 g/20 mL injectionIntravenousKedrion BiopharmaUS FDAAvailable on request
Albumin human 10 g/50 mL injectionIntravenousGeneric name—US FDAAvailable on request
Albumin human 12.5 g/250 mL injectionIntravenousGeneric name—US FDAAvailable on request
Albumin human 12.5 g/50 mL injectionIntravenousGeneric name—US FDAAvailable on request
Albumin human 20 g/100 mL injectionIntravenousGeneric name—US FDAAvailable on request
Albumin human 25 g/100 mL injectionIntravenousGeneric name—US FDAAvailable on request
Albumin human 25 g/500 mL injectionIntravenousGeneric name—US FDAAvailable on request
Albumin human 5 g/100 mL injectionIntravenousGeneric name—US FDAAvailable on request
Albuminex 12.5 g/250 mL injectionIntravenousBplUS FDAAvailable on request
Albuminex 12.5 g/50 mL injectionIntravenousBplUS FDAAvailable on request
Albuminex 25 g/100 mL injectionIntravenousBplUS FDAAvailable on request
Albuminex 25 g/500 mL injectionIntravenousBplUS FDAAvailable on request
Alburx 12.5 g/250 mL injectionIntravenousCSL BehringUS FDAAvailable on request
AlbuRx 12.5 g/50 mL injectionIntravenousCSL BehringUS FDAAvailable on request
AlbuRx 25 g/100 mL injectionIntravenousCSL BehringUS FDAAvailable on request
Alburx 25 g/500 mL injectionIntravenousCSL BehringUS FDAAvailable on request
Albutein 2.5 g/50 mL injectionIntravenousGrifolsUS FDAAvailable on request
Albutein 5 g/20 mL injectionIntravenousGrifolsUS FDAAvailable on request
Flexbumin 12.5 g/250 mL injectionIntravenousTakeda PharmaceuticalsUS FDAAvailable on request
Flexbumin 12.5 g/50 mL injectionIntravenousTakeda PharmaceuticalsUS FDAAvailable on request
Flexbumin 25 g/100 mL injectionIntravenousTakeda PharmaceuticalsUS FDAAvailable on request
Human Albumin Grifols 20 g/100 mL injectionIntravenousGrifolsUS FDAAvailable on request
Kedbumin 12.5 g/50 mL injectionIntravenousKedrion Sp AUS FDAAvailable on request
Kedbumin 25 g/100 mL injectionIntravenousKedrion Sp AUS FDAAvailable on request
Plasbumin 10 g/50 mL injectionIntravenousGrifolsUS FDAAvailable on request
Plasbumin 12.5 g/250 mL injectionIntravenousGrifolsUS FDAAvailable on request
Plasbumin 12.5 g/50 mL injectionIntravenousGrifolsUS FDAAvailable on request
Plasbumin 2.5 g/50 mL injectionIntravenousGrifolsUS FDAAvailable on request
Plasbumin 20 g/100 mL injectionIntravenousGrifolsUS FDAAvailable on request
Plasbumin 25 g/100 mL injectionIntravenousGrifolsUS FDAAvailable on request
Plasbumin 25 g/500 mL injectionIntravenousGrifolsUS FDAAvailable on request
Plasbumin 5 g/20 mL injectionIntravenousGrifolsUS FDAAvailable on request
Plasmanate 12.5 g/250 mL injectionIntravenousGrifolsUS FDAAvailable on request

Brands by market

9 brand names across 1 markets.

Brand names by country

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 31 December 1997Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Albumin human available for export from India?

Yes, on request. MedsAcross lists 45 presentations of Albumin human and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Albumin human have?

The catalogue lists 10 brand names for Albumin human, including Albuked, Albuminex, AlbuRx, Alburx, Albutein, Flexbumin, Human Albumin Grifols, Kedbumin.

Is Albumin human approved by the US FDA?

Yes. The US FDA first approved Albumin human on 31 December 1997, according to Drugs@FDA.

Does Albumin human need cold chain shipping?

No listed presentation of Albumin human is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

References

  1. KEDBUMIN prescribing information (Kedrion Sp A). U.S. National Library of Medicine, DailyMed. Retrieved 20 August 2026

Request Albumin human for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.